Publications by authors named "Manfred Kindler"

Claim this Profile
B
Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer.
Julia Quidde, Laura Denne, Andreas Kutscheidt, Manfred Kindler, Andreas Kirsch

Oncol Res Treat· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional study.
Lothar Bergmann, Ulrich Kube, Christian Doehn, Thomas Steiner, Peter J Goebell, Manfred Kindler

BMC Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results.
Ralf Hofheinz, Volker Petersen, Manfred Kindler, Mathias Schulze, Joerg Seraphin

BMC Cancer· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy: results of an interim analysis of a non-interventional study.
Lothar Bergmann, Peter J Goebell, Ulrich Kube, Manfred Kindler, Edwin Herrmann

Onkologie· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.
Ulf W Tunn, Amulf Stenzl, Wolfgang Schultze-Seemann, Arne Strauss, Manfred Kindler

Can J Urol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group.
Uwe Pelzer, Dirk Arnold, Peter Reitzig, Julia Herrenberger, Friedrich Wilhelm Korsten, Manfred Kindler

Cancer Chemother Pharmacol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid and sustained influence of intravenous zoledronic Acid on course of pain and analgesics consumption in patients with cancer with bone metastases: a multicenter open-label study over 1 year.
Albrecht Kretzschmar, Thomas Wiege, Salah-Eddin Al-Batran, Hans Fokke Hinrichs, Manfred Kindler

Support Cancer Ther· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancer.
M Karthaus, Harald Ballo, Wolgang Abenhardt, Tilmann Steinmetz, Thomas Geer, Manfred Kindler

Oncology· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis